• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arena Pharmaceuticals, Inc. - Common Stock (NQ:ARNA)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 99.87 (1)
Ask (Size) 100.00 (88)
Prev. Close 99.98
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 61,074,416
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NeurAxis: Should You Buy This IPO? ↗
February 08, 2023
As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype. 
Via Talk Markets
News headline image
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution ↗
February 06, 2023
As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio. 
Via Talk Markets

Performance

More News

Read More
News headline image
Arena Pharmaceuticals Inc. Climbs To Annual-High Share Price ↗
March 10, 2022
Via Benzinga
Arena Pharmaceuticals Inc. (ARNA) Climbs to Annual-High Share Price
March 10, 2022
Via Investor Brand Network
Arena Pharmaceuticals Inc. (ARNA) Climbs to Annual-High Share Price
March 10, 2022
Via Investor Brand Network
News headline image
7 Biotech Stocks With Key Catalysts in March ↗
March 09, 2022
Via InvestorPlace
News headline image
Expert Ratings For Arena Pharmaceuticals ↗
February 09, 2022
Via Benzinga
News headline image
Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers ↗
March 08, 2022
Via Benzinga
News headline image
Futures Rebound On "Massive" EU Bond Stimulus Plan; Nickel Halted After Record Surge, Gold Over $2000 ↗
March 08, 2022
Via Talk Markets
News headline image
Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY ↗
February 24, 2022
Via Benzinga
News headline image
Arena Pharmaceuticals: Q4 Earnings Insights ↗
February 23, 2022
Via Benzinga
News headline image
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates
February 23, 2022
From Arena Pharmaceuticals, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗
February 23, 2022
Via Benzinga
News headline image
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2022
From Arena Pharmaceuticals, Inc.
Via Business Wire
News headline image
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗
February 20, 2022
Via Benzinga
News headline image
Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23
February 09, 2022
From Arena Pharmaceuticals, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022 ↗
February 09, 2022
Via Benzinga
News headline image
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 18, 2022
From Arena Pharmaceuticals, Inc.
Via Business Wire
News headline image
7 Long-Term Stocks to Buy and Hold Until 2030 ↗
January 17, 2022
Via InvestorPlace
News headline image
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 21, 2021
From Arena Pharmaceuticals, Inc.
Via Business Wire
News headline image
10 Biggest Price Target Changes For Tuesday ↗
December 21, 2021
Via Benzinga
News headline image
Benzinga's Bulls And Bears Of The Past Week: Pfizer, Bank Of America, Beyond Meat, GameStop, AMC, Overstock And More ↗
December 18, 2021
Via Benzinga
News headline image
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More ↗
December 17, 2021
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021 ↗
December 14, 2021
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Arena Pharmaceuticals ↗
December 14, 2021
Via Benzinga

Frequently Asked Questions

Is Arena Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Arena Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Arena Pharmaceuticals, Inc. - Common Stock trade on?
Arena Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Arena Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Arena Pharmaceuticals, Inc. - Common Stock is ARNA on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap